DK609889A - Vandig doxorubicinoploesning - Google Patents

Vandig doxorubicinoploesning Download PDF

Info

Publication number: DK609889A
Authority: DK; Denmark
Prior art keywords: doxorubicin solution; doxorubicin; physiologically acceptable; solution; aqueous doxorubicin
Prior art date: 1988-12-05

Application number

DK609889A

Other languages

English (en)

Other versions

DK609889D0 (da

Inventor

Murray A Kaplan

Robert K Perrone

Joseph B Bogardus

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-12-05

Filing date

1989-12-04

Publication date

1990-06-06

1989-12-04 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

1989-12-04 Publication of DK609889D0 publication Critical patent/DK609889D0/da

1990-06-06 Publication of DK609889A publication Critical patent/DK609889A/da

Links

AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 title abstract 6
229960004679 doxorubicin Drugs 0.000 title abstract 3
239000000243 solution Substances 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 1
239000003963 antioxidant agent Substances 0.000 abstract 1
230000003078 antioxidant effect Effects 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
YNJORDSKPXMABC-UHFFFAOYSA-M sodium;2-hydroxypropane-2-sulfonate Chemical compound [Na+].CC(C)(O)S([O-])(=O)=O YNJORDSKPXMABC-UHFFFAOYSA-M 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)
Lubricants (AREA)
Lubrication Of Internal Combustion Engines (AREA)
Steroid Compounds (AREA)

DK609889A 1988-12-05 1989-12-04 Vandig doxorubicinoploesning DK609889A (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US27962788A	1988-12-05	1988-12-05

Publications (2)

Publication Number	Publication Date
DK609889D0 DK609889D0 (da)	1989-12-04
DK609889A true DK609889A (da)	1990-06-06

Family

ID=23069771

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK609889A DK609889A (da)	1988-12-05	1989-12-04	Vandig doxorubicinoploesning

Country Status (20)

Country	Link
EP (1)	EP0372888B1 (da)
JP (1)	JPH02200637A (da)
KR (1)	KR920001460B1 (da)
AT (1)	ATE78402T1 (da)
AU (1)	AU612916B2 (da)
DD (1)	DD295990A5 (da)
DE (1)	DE68902223T2 (da)
DK (1)	DK609889A (da)
ES (1)	ES2044148T3 (da)
FI (1)	FI895733A7 (da)
GR (1)	GR3005391T3 (da)
HU (1)	HU204704B (da)
IE (1)	IE893867L (da)
IL (1)	IL92541A0 (da)
NO (1)	NO894811L (da)
NZ (1)	NZ231602A (da)
OA (1)	OA09898A (da)
PT (1)	PT92483B (da)
YU (1)	YU226189A (da)
ZA (1)	ZA899248B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006085336A2 (en) *	2005-02-11	2006-08-17	Dabur Pharma Limited	Stabilized anthracycline glycoside pharmaceutical compositions
EP3417864A4 (en)	2016-02-16	2019-08-21	General Incorporated Association Pharma Valley Project Supporting Organisation	IMMUNOSUPPRESSION TENDERING AGENT AND USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8519452D0 (en) *	1985-08-02	1985-09-11	Erba Farmitalia	Injectable solutions
FI883338A7 (fi) *	1987-07-16	1989-01-17	Bristol Myers Squibb Co	Doksorubisiinihydrokloridin vesiliuoksia

1989
- 1989-11-30 FI FI895733A patent/FI895733A7/fi not_active Application Discontinuation
- 1989-12-01 NZ NZ231602A patent/NZ231602A/en unknown
- 1989-12-01 NO NO89894811A patent/NO894811L/no unknown
- 1989-12-04 PT PT92483A patent/PT92483B/pt not_active IP Right Cessation
- 1989-12-04 ES ES89312625T patent/ES2044148T3/es not_active Expired - Lifetime
- 1989-12-04 YU YU02261/89A patent/YU226189A/xx unknown
- 1989-12-04 JP JP1315123A patent/JPH02200637A/ja active Pending
- 1989-12-04 KR KR1019890017864A patent/KR920001460B1/ko not_active Expired
- 1989-12-04 ZA ZA899248A patent/ZA899248B/xx unknown
- 1989-12-04 IL IL92541A patent/IL92541A0/xx unknown
- 1989-12-04 DK DK609889A patent/DK609889A/da not_active Application Discontinuation
- 1989-12-04 OA OA59689A patent/OA09898A/fr unknown
- 1989-12-04 DE DE8989312625T patent/DE68902223T2/de not_active Expired - Fee Related
- 1989-12-04 AT AT89312625T patent/ATE78402T1/de not_active IP Right Cessation
- 1989-12-04 IE IE893867A patent/IE893867L/xx unknown
- 1989-12-04 EP EP89312625A patent/EP0372888B1/en not_active Expired - Lifetime
- 1989-12-05 AU AU45915/89A patent/AU612916B2/en not_active Ceased
- 1989-12-05 HU HU896426A patent/HU204704B/hu not_active IP Right Cessation
- 1989-12-05 DD DD89335266A patent/DD295990A5/de not_active IP Right Cessation
1992
- 1992-08-10 GR GR920400652T patent/GR3005391T3/el unknown

Also Published As

Publication number	Publication date
JPH02200637A (ja)	1990-08-08
NZ231602A (en)	1991-12-23
OA09898A (fr)	1994-09-15
EP0372888B1 (en)	1992-07-22
DK609889D0 (da)	1989-12-04
DE68902223T2 (de)	1993-01-14
KR920001460B1 (ko)	1992-02-14
PT92483B (pt)	1995-08-09
DE68902223D1 (de)	1992-08-27
AU4591589A (en)	1990-06-07
ATE78402T1 (de)	1992-08-15
GR3005391T3 (da)	1993-05-24
DD295990A5 (de)	1991-11-21
FI895733A0 (fi)	1989-11-30
HU896426D0 (en)	1990-02-28
YU226189A (en)	1991-02-28
PT92483A (pt)	1990-06-29
NO894811D0 (no)	1989-12-01
EP0372888A1 (en)	1990-06-13
FI895733A7 (fi)	1990-06-06
ES2044148T3 (es)	1994-01-01
HU204704B (en)	1992-02-28
IE893867L (en)	1990-06-05
ZA899248B (en)	1990-08-29
HUT52961A (en)	1990-09-28
NO894811L (no)	1990-06-06
IL92541A0 (en)	1990-08-31
AU612916B2 (en)	1991-07-18
KR900009081A (ko)	1990-07-02

Legal Events

Date	Code	Title	Description
1994-08-22	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
DE59010810D1 (de)	1998-04-16	Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
SE7903817L (sv)	1979-11-04	Moranolinderivat
NO863061L (no)	1987-02-02	Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
DK0490549T3 (da)	1995-08-21	Stabilisering af calcitonin-holdige farmaceutiske præparater
FI854167A0 (fi)	1985-10-24	Mun- och tandvaordsmedel.
FI883338A0 (fi)	1988-07-13	Vattenloesningar av doxorubicinhydroklorid.
SE9102604D0 (sv)	1991-09-10	Farmaceutiska kompositioner innehaallande furanderivat
DK609889A (da)	1990-06-06	Vandig doxorubicinoploesning
DE69003061D1 (de)	1993-10-07	Protein enthaltende wässerige Lösungen.
GR3007469T3 (da)	1993-07-30
ES8705866A1 (es)	1987-06-01	Procedimiento de preparar sales fungicidas
JPS5344592A (en)	1978-04-21	Condensed quinazoline derivatives
DK214884A (da)	1984-11-03	Chlorphenoxyacetatderivat